Assessing mortality differences across acute respiratory failure management strategies in Covid-19.
Acute respiratory failure
Covid-19
Mechanical ventilation
Journal
Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
16
09
2021
revised:
14
02
2022
accepted:
06
04
2022
pubmed:
2
5
2022
medline:
9
6
2022
entrez:
1
5
2022
Statut:
ppublish
Résumé
Prolonged observation could avoid invasive mechanical ventilation (IMV) and related risks in patients with Covid-19 acute respiratory failure (ARF) compared to initiating early IMV. We aimed to determine the association between ARF management strategy and in-hospital mortality. Patients in the Weill Cornell Covid-19 registry who developed ARF between March 5 - March 25, 2020 were exposed to an early IMV strategy; between March 26 - April 1, 2020 to an intermediate strategy; and after April 2 to prolonged observation. Cox proportional hazards regression was used to model in-hospital mortality and test an interaction between ARF management strategy and modified sequential organ failure assessment (mSOFA). Among 632 patients with ARF, 24% of patients in the early IMV strategy died versus 28% in prolonged observation. At lower mSOFA, prolonged observation was associated with lower mortality compared to early IMV (at mSOFA = 0, HR 0.16 [95% CI 0.04-0.57]). Mortality risk increased in the prolonged observation strategy group with each point increase in mSOFA score (HR 1.29 [95% CI 1.10-1.51], p = 0.002). In Covid-19 ARF, prolonged observation was associated with a mortality benefit at lower mSOFA scores, and increased mortality at higher mSOFA scores compared to early IMV.
Identifiants
pubmed: 35490502
pii: S0883-9441(22)00074-0
doi: 10.1016/j.jcrc.2022.154045
pmc: PMC9049881
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
154045Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL151876
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL134629
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
Am J Respir Crit Care Med. 2021 Mar 1;203(5):565-574
pubmed: 33306946
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1319-1320
pubmed: 32281885
J Hosp Med. 2021 Feb;16(2):90-92
pubmed: 33147129
Clin Chest Med. 2016 Dec;37(4):633-646
pubmed: 27842744
Ann Am Thorac Soc. 2020 Feb;17(2):249-252
pubmed: 31618603
JAMA Intern Med. 2021 Apr 1;181(4):471-478
pubmed: 33351068
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32430410
Eur Respir J. 2021 Feb 17;57(2):
pubmed: 33033151
Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442
pubmed: 27626833
Crit Care Med. 2020 Nov;48(11):e1045-e1053
pubmed: 32804790
Am J Respir Crit Care Med. 2020 Oct 1;202(7):1039-1042
pubmed: 32758000
EClinicalMedicine. 2020 Nov;28:100570
pubmed: 33043285
N Engl J Med. 2013 Jun 6;368(23):2159-68
pubmed: 23688302
Chest. 2007 Aug;132(2):410-7
pubmed: 17573487
Lancet Reg Health Eur. 2021 Apr;3:100041
pubmed: 33870249
Ann Am Thorac Soc. 2020 Sep;17(9):1158-1161
pubmed: 32432896
Respir Care. 2019 Jun;64(6):735-742
pubmed: 31110041
JAMA. 2002 Dec 11;288(22):2859-67
pubmed: 12472328
Lancet Respir Med. 2021 Mar;9(3):239-250
pubmed: 33428871
J Clin Invest. 1997 Mar 1;99(5):944-52
pubmed: 9062352
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Crit Care Med. 2016 Jan;44(1):120-9
pubmed: 26474112
Intensive Care Med. 2020 May;46(5):888-906
pubmed: 32157357
Chest. 2016 Nov;150(5):1109-1117
pubmed: 27477213
N Engl J Med. 2020 Nov 19;383(21):2030-2040
pubmed: 33031652
JAMA. 2000 Jan 12;283(2):235-41
pubmed: 10634340
N Engl J Med. 2020 Dec 17;383(25):2451-2460
pubmed: 32412710
Intensive Care Med. 1993;19(5):256-64
pubmed: 8408934
Am J Respir Crit Care Med. 2021 Feb 15;203(4):504-508
pubmed: 32986956
JAMA. 1999 Jul 7;282(1):54-61
pubmed: 10404912
AMIA Annu Symp Proc. 2018 Apr 16;2017:1581-1588
pubmed: 29854228
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1337-1344
pubmed: 32298146
J Intensive Care. 2020 Jun 22;8:41
pubmed: 32587703
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
JAMA. 2016 Dec 13;316(22):2427-2429
pubmed: 27835709
Crit Care Explor. 2020 Oct 21;2(10):e0254
pubmed: 33134945